CRISPR Therapeutics CRSP

Recent headlines

• +0.87

  Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body

  nature.com · Nov 13
• +0.42

  A first for CRISPR: powerful prime editing alters DNA directly in the human body

  nature.com · Oct 27
• +0.00

  Bigger than CRISPR? A guide to the latest genome editors

  nature.com · Sep 30
• +0.30

  CRISPR crops are coming to Europe — why bolder would be betterNico De Storme

  nature.com · Sep 18
• -0.88

  Bizarre CRISPR enzyme kills cancer cells by shredding their DNA

  nature.com · Jul 29
• +0.40

  CRISPR’s next act: the companies editing the epigenome to treat disease

  nature.com · Jul 01

Latest SEC filings

• SCHEDULE 13G/A
  Passive stake (5%+) 2026-11-13
• SCHEDULE 13G
  Passive stake (5%+) 2026-11-10
• 10-Q
  Quarterly report 2026-11-02
• 8-K
  Current report 2026-11-02
• 8-K
  Current report 2026-10-19 · 8-K Item 5.02: Director or officer change
• SCHEDULE 13G/A
  Passive stake (5%+) 2026-08-14
• 10-Q
  Quarterly report 2026-08-03
• 8-K
  Current report 2026-08-03
• SCHEDULE 13G/A
  Passive stake (5%+) 2026-07-27
• S-8
  Employee stock plan registration 2026-06-05
• 8-K
  Current report 2026-06-04 · 8-K Item 5.02: Director or officer change
• SCHEDULE 13G/A
  Passive stake (5%+) 2026-05-15

Plus 21 insider trading forms (Forms 3, 4, 5 and 144) in the last 90 days, not listed here.